Ledger.Open graph →
SEC Form D · filed July 8, 2015

Sarentis Therapeutics Inc

Offering
$1.0M
Sold
$750K
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
NEW YORK, NY
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (3)

Denise Barbut · Bar Harbor, MEExec · Director · PromoterRael Nurick · New York, NYExec · Director · PromoterLewis K. Johnson · Charlotte, NCExec · Director · Promoter

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗